CytRx Corporation (CYTR)
CytRx Corporation Revenues
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CYTR Revenues Range, Past 5 Years
| Minimum | 0.10M | Dec 2009 |
| Maximum | 6.954M | Sep 2009 |
| Average | 1.686M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these CYTR related companies
CYTR News
$PACB nice , out of most, now my pick is $CYTR l/f watch this one
about 3 days ago by 3DTradingtrader
about 3 days ago by 3DTradingtrader
CytRx Announces Presentation of Complete Clinical Data from INNO-206 Phase 1b/2 Trial at ASCO
May 07, 8:30AM Business Wire
May 07, 8:30AM Business Wire
CytRx (CYTR) Announces Favorable Ruling from NASDAQ Panel, Announces Extension
Apr 23, 8:34AM Street Insider
Apr 23, 8:34AM Street Insider
Southern California Investment Forum Hosts an Investor Gathering in San Francisco and Las Vegas on April 24th -25th
Apr 23, 6:00AM Business Wire
Apr 23, 6:00AM Business Wire
$PPHM looking like $CYTR collapse, backing up truck under $0.25 for a quick double
about 40 days ago by HighGrowthFinancial
about 40 days ago by HighGrowthFinancial
CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology
Apr 12, 8:30AM Benzinga
Apr 12, 8:30AM Benzinga
INSIDER PIGGY BACK: Stopped on final 33% of held L: $CYTR from .32 @ .37 for +15%. Will revisit the name under .33 for another L. ALL OUT.
about 49 days ago by Legacy_Trades
about 49 days ago by Legacy_Trades
$CYTR filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3B9h
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
$CYTR sold half from .32 but the way this is holding up I'll hang onto the rest.
about 67 days ago by ea32da32
about 67 days ago by ea32da32
INSIDER PIGGY BACK - SCALP: Sold another 33% L: $CYTR from $0.32 @ $0.41 (200SMA target post 3/19); +$0.09 or +28%. Hold 33%, stop to entry.
about 67 days ago by Legacy_Trades
about 67 days ago by Legacy_Trades
INSIDER PIGGY BACK - SCALP: Sold 33% of L: $CYTR from $0.32 @ $0.36 for +$0.04 or +12.5%. Stop < $0.29 w/ next target SELL of 33% @ $0.41.
about 69 days ago by Legacy_Trades
about 69 days ago by Legacy_Trades
Q & A-What to look for when making piggy back trades on INSIDER BUYS: Relates to L: $CYTR & L: $MCZ: @Legacy_Trades http://stks.co/2nsz
about 77 days ago by WallStJesus
about 77 days ago by WallStJesus
CytRx to Present at the Roth Capital Partners Annual OC Growth Stock Conference
Mar 05, 8:30AM Business Wire
Mar 05, 8:30AM Business Wire
$CYTR http://stks.co/2b43 30min: Watching price relative to the 50 (blue line)
about 90 days ago by Tr8r_x
about 90 days ago by Tr8r_x
CytRx Receives Notification of Non-Compliance with NASDAQ Minimum Bid Requirement
Feb 17, 8:31AM Benzinga
Feb 17, 8:31AM Benzinga
CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients
Dec 12, 8:31AM Street Insider
Dec 12, 8:31AM Street Insider
CytRx to Present at Lazard Capital Markets 8th Annual Healthcare Conference
Nov 07, 8:30AM Business Wire
Nov 07, 8:30AM Business Wire
CytRx (CYTR) Reports Favorable INNO-206 Results from Ongoing Phase 1b/2
Oct 31, 8:32AM Street Insider
Oct 31, 8:32AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYTR | 3.45 | +0.20 | +6.15% | 73.17M |
| CYTK | 0.93 | +0.02 | +2.20% | 71.03M |
| CVBK | 0.86 | -0.08 | -8.51% | 2.262M |
| CVA | 15.79 | -0.03 | -0.19% | 2.149B |
| CV | 35.13 | -0.02 | -0.06% | 473.55M |
| CUZ | 7.42 | +0.09 | +1.23% | 772.72M |
| CUTR | 6.94 | -0.20 | -2.80% | 96.81M |
| CUT | 16.04 | +0.04 | +0.24% | |
| CURE | 39.59 | +0.00 | +0.00% | |
| CUR | 0.94 | -0.01 | -1.05% | 51.40M |
